Expert Insights & Commentary
BLOG
The South Florida Venture Tech Chronicle Blog goes beyond the headlines.
Here, founders, investors, and industry experts share their perspectives on emerging technologies, investment strategies, and the challenges shaping our innovation ecosystem.
Expect thought leadership, data-driven opinions, and long-form features that deepen understanding of where tech is headed next.
DermaSensor Named Finalist in the National 2026 Digital Health & AI Awards
Miami-based medical technology company DermaSensor has been named a finalist in the 2026 Digital Health & AI Awards in the Cancer, Screening & Early Detection category. Founded by Cody Simmons, the company developed an FDA-authorized handheld device that uses artificial intelligence and spectroscopy to help healthcare providers assess suspicious skin lesions. With more than 45,000 lesions scanned and approximately $48 million in total funding, DermaSensor continues to expand its clinical adoption and commercial reach. The national recognition highlights South Florida's growing role in AI-powered healthcare innovation, with winners set to be announced at HLTH 2026 in November.
DermaSensor Adds $5M as AI Skin Cancer Technology Moves Into National Scale-Up
Miami-based DermaSensor has secured approximately $5 million in new financing as it advances the national commercialization of its AI-powered skin cancer assessment device. The company’s latest funding includes a $4 million Series B extension and more than $1 million from a Wefunder community investment campaign. With more than 45,000 suspicious lesions scanned and new partnerships with Henry Schein, healthcare systems, and the VA market, DermaSensor is shifting from clinical validation toward broad adoption. The milestone highlights South Florida’s growing role in medical technology and healthcare innovation.